Peter Matthias Villiger

机构：Center for Rheumatology · ORCID：0000-0002-8859-9964

发表论文 270 篇 · 总被引 13590 次 · h-index 62

代表论文

Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study (2021 · The Lancet Rheumatology · 被引 71)
Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis (2021 · Lara D. Veeken · 被引 63)
Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matter (2022 · RMD Open · 被引 39)
Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy (2022 · Lara D. Veeken · 被引 37)
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases (2022 · Autoimmunity Reviews · 被引 33)
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis (2023 · Arthritis Research & Therapy · 被引 32)